Transplantation of haploidentical-hematopoietic stem cells combined with two kind of third part cells for chronic aplastic anemia: one case report.
10.7534/j.issn.1009-2137.2013.06.029
- Author:
Li-Xin XU
1
;
Yong-Bin CAO
1
;
Zhou-Yang LIU
1
;
Ya-Mei WU
1
;
Zhi-Hong WANG
1
;
Bei YAN
1
;
Wan-Ming DA
2
;
Xiao-Xiong WU
3
Author Information
1. Department of Hematology, The First Affiliated Hospital of Chinese PLA General Hospital, Beijing 100048, China.
2. Department of Hematology, Chinese PLA General Hospital, Beijing 100048, China.
3. Department of Hematology, The First Affiliated Hospital of Chinese PLA General Hospital, Beijing 100048, China. E-mail: xiongwuxiao@sohu.com.
- Publication Type:Case Reports
- MeSH:
Anemia, Aplastic;
therapy;
Child;
Female;
Haploidy;
Hematopoietic Stem Cell Transplantation;
methods;
Humans;
Transplantation, Homologous
- From:
Journal of Experimental Hematology
2013;21(6):1522-1525
- CountryChina
- Language:Chinese
-
Abstract:
This study was purposed to investigate the safety and effectivity of haploidentical stem cell transplantation for chronic aplastic anemia (CAA) by using two kind of third part cells: umbilical cord derived mesenchymal stem cells (hUC-MSC) and haploidentical umbilical cord blood cells. The patient is a girl of 12 year old with CAA for 11 years. The donor was her mother. Graft come from haploidentical hematopoietic bone marrow and peripheral blood mobilized with granulocyte colony-stimulating factor (G-CSF). The human umbilical cord derived mesenchymal stem cells and the haploidentical umbilical cord blood cells were transferred as third pard of cell. The graft-versus-host disease (GVHD) was prevented with CsA, MTX, ATG, CD25 and mycophenolate mofetil. The results indicated that the infused numbers of MNC and CD34(+) cells of donor were 7.92×10(8)/kg and 3.78×10(6)/kg, respectively. The numbers of neutrophils and platelets were over 0.5×10(9)/L and 20×10(9)/L on days 12 and 14, respectively. On day 35 the chimeras accounted for 94%. No serious complications appeared up to now. In conclusion, the preliminary results suggest that transplantation of haploidentical hematopoietic stem cells combined with two kind of third part cells is safe and satisfactory.
